NCT03691324

Brief Summary

Inhalation drugs are essential in the treatment of COPD, in controlling symptoms and preventing exacerbations. The aim of this pilot study is to collect data necessary for the planning of future efficacy trials. We plan to assess the value of providing training in inhalation technique to hospitalized COPD patients. Data on rehospitalizations will be collected from the hospital's medical records and from the National Patient Registry . The inhalation technique of all recruited patients will de assessed at baseline. The patients will then be randomised 1:1 to the intervention or standard care group. The intervention consists of a drug counselling, focusing on inhalation technique. In addition patients in the intervention group will have their medicines personally delivered from the hospital pharmacy at discharge (discharge service). Patients will be asked to fill in questionnaires evaluating the inhalation training and the discharge service

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 26, 2018

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

September 28, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 1, 2018

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2021

Completed
Last Updated

February 25, 2021

Status Verified

March 1, 2020

Enrollment Period

2.1 years

First QC Date

September 28, 2018

Last Update Submit

February 23, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time to first readmission

    Time to readmission based on data from the national patient registry

    One year after discharge of the last patient

Secondary Outcomes (2)

  • Improvement in patient reported symptom score (CAT-score) from baseline to 2 months after discharge

    2 months after discharge

  • Proportion of patients readmitted 3 months after discharge

    3 months

Study Arms (2)

Intervention

EXPERIMENTAL

Patients receive an inhalation technique education based on standardized procedure developed by The Norwegian Pharmacy Association. In addition they are offered a discharge service day before or the day of discharge; a second inhalation training and dispensing of their prescribed COPD- medicines.

Other: Inhalation technique training and discharge service

Standard care

NO INTERVENTION

Patients receive standard care and follow up of their COPD-treatment

Interventions

Patient drug counselling one-to-one, focusing on inhalation drugs and technique

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients admitted to the pulmonary ward, the Medical Department, Oslo University Hospital, Oslo, Norway

You may not qualify if:

  • Patients
  • previously included to the study
  • usually not administering their inhalation drugs themselves
  • using nebulizer chamber with their drug
  • who are contagious, thus restricting accessibility of personnel
  • who are not able to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oslo University Hospital

Oslo, N-0424, Norway

Location

Related Publications (1)

  • Kebede AT, Trapnes E, Lea M, Abrahamsen B, Mathiesen L. Effect of pharmacist-led inhaler technique assessment service on readmissions in hospitalized COPD patients: a randomized, controlled pilot study. BMC Pulm Med. 2022 May 27;22(1):210. doi: 10.1186/s12890-022-02004-z.

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Liv Mathiesen, PhD

    Oslo University Collage

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

September 28, 2018

First Posted

October 1, 2018

Study Start

September 26, 2018

Primary Completion

November 15, 2020

Study Completion

January 15, 2021

Last Updated

February 25, 2021

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Sharing of individual patient data is not allowed by the approving authority

Locations